Editorial: Liver and Non‐Liver Outcomes Between Different Subtypes of Steatotic Liver Disease

Documenti analoghi

• Editorial: Revolutionising Steatotic Liver Disease Diagnosis With Phosphatidylethanol
  di: Karen Cheuk‐Ying Ho, et al.
  Pubblicazione: (2025)
• Subtype Differences in Major Adverse Liver Outcomes and Cardiovascular Events and Mortality in Steatotic Liver Disease: A UK Biobank Analysis
  di: Takao Miwa, et al.
  Pubblicazione: (2026)
• Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication
  di: Pei‐Chien Tsai, et al.
  Pubblicazione: (2025)
• Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States
  di: Kelly Torosian, et al.
  Pubblicazione: (2025)
• Editorial: Time to Genotype—Genetic Risk and Prognosis in Steatotic Liver Disease
  di: Rosellina M. Mancina, et al.
  Pubblicazione: (2025)